An Unusual Case of Pulmonary Mucormycosis

Area of Science:

• Mycology
• Transplant Infectious Diseases
• Pulmonology

Background:

• Invasive fungal infections, particularly mucormycosis, pose significant risks in solid organ transplant recipients.
• Mucormycosis is an aggressive angioinvasive infection with high mortality, often linked to immunocompromise and diabetes.
• Diagnosis can be challenging, necessitating a high index of suspicion.

Observation:

• This case details the first report of cavitating pulmonary mucormycosis in a renal transplant recipient.
• The causative agent was an unusual species within the order Mucorales.
• The patient presented with a complex fungal infection requiring multidisciplinary management.

Findings:

• Successful treatment involved a combination of surgical lobectomy and antifungal therapy.
• The regimen included amphotericin B and posaconazole.
• The patient achieved disease-free status and remains in remission on posaconazole monotherapy.

Implications:

• Aggressive and early treatment, including newer antifungal agents, can significantly improve outcomes for invasive mucormycosis.
• This case highlights the importance of considering unusual fungal pathogens in immunocompromised patients.
• Combination therapy and targeted antifungal use show promise in managing severe fungal infections post-transplant.